The myxobacterium, Myxococcus virescens strain Mx v48 produced a family of at least 12 closely related antibiotics, the myxovirescins***.
coll. After 12 hours, inhibition zones could be observed in the lawn of the indicator bacterium, and producing colonies with zones larger than average were picked, purified, and tested in liquid culture. Mutant Mx v48-M7 produced 0.5,ug/ml, and mutant Mx v48-M8 (DSM 2177) obtained from Mx v48-M7 by the same procedure 2.0,ug/ml. Next we selected clones which were able to grow in the presence of 0.5 % (NH4)2SO4 by cultivating Mx v48-M8 in PLM to which increasing amounts of the salt were added. Surprisingly, some of these clones were superior producers of the antibiotic, as e.g. Mx v48-M10 with 8µg/ml, and it was produced in presence or absence of (NH4)2SO4. The production behavior and the generation time of the strain were the same as those of the initial mutant Mx v48-M3.
Fermentation
For mass production of the antibiotic, Mx v48 and its mutants were grown in fermentors (Giovanola Freres, Manthey, Switzerland) equipped with a circulating pump stirrer system ("intensor system") and The temperature was 32°C, the agitation 400 r.p.m., and the aeration rate 0.2 v/v/m. The bacteria grew exponentially during the first 10 hours. Then followed a linear growth phase of about 30 hours, during which the pO2 remained nearly constant. After this, the pO2 began to increase, and the antibiotic was produced. The fermentation was stopped 20 hours after the beginning of the production phase.
Isolation of the Antibiotic
The culture broth was separated from the cells and from insoluble constituents of the medium by centrifugation. Extraction of the broth with ethyl acetate yielded the crude antibiotic. The crude extract was concentrated under reduced pressure at 40°C. Distribution between heptane and methanol eliminated contaminating material, leaving the antibiotic in the methanol phase. The concentrated methanol phase was further purified by preparative HPLC (Waters Prep LC 500) on a reversed phase silica gel column (RP-8) with methanol -water, 9: 1 as the eluant. At this stage the active fraction consisted of at least 12 chemically different and biologically active compounds which could be separated by repeated HPLC on silica gel RP-18. One of these components was formed in large excess and was named myxovirescin A') ( Fig. 1 higher concentrations also some pseudomonads and Gram-positive bacteria ( Table 1) . When myxovirescin A (2 tg/ml) was added to a culture of Escherichia toll, 99.7 % of the cells lost the ability to form colonies within 30 minutes. The effect of the antibiotic was thus relatively slow but irreversible. The dose response curves of 4 Gram-negative bacteria tested differed in a characteristic way from that of Staphylococcus aureus (Fig. 2) . While the former quickly reached the inhibition maximum when the antibiotic concentration was increased beyond the threshold concentration at which an effect could be observed, growth of S. aureus was gradually inhibited over a wide range of concentrations beginning at very low levels.
The minimal inhibitory concentration (MIC) for E. coli, but not for S. aureus, was strongly influenced by the presence of calcium ions (Fig. 3) . Already 0.1 % CaCl2.2H2O (about 7 mm) made E. coil highly resistant to myxovirescin A. Magnesium and barium ions had no such effect.
EDTA acted synergistically with myxovirescin A (Fig. 4) . With Pseudomonas aeruginosa, the MIC was reduced by 0.01 % EDTA (disodium salt) from 30 µg/ml to 7 µg/ml. The effect of EDTA could partially be reversed by the addition of calcium ions (Fig. 4 ). E. coil could also be protected against myxovirescin A by bovine serum (Fig. 5 ). In bovine serum (Oxoid) with 0.5% peptone and 0.5% glucose, the MIC was 20 eg/ml instead of 1µg/ml. A 10 % addition to peptone liquid medium of the albumin fraction of bovine serum increased the MIC only from 1 to 3 hg/ml. However, when small quantities of lecithin (0.5 mg/ml) were added to peptone liquid medium, the inhibitory effect of myxovirescin A (2 pg/m1) on E. coil Al was completely neutralized. Cholesterol, in contrast, did not interfere with the activity of the antibiotic.
To get an idea about the mechanism of action of myxovirescin A, its influence on DNA, protein and murein synthesis was studied with the usual tracer technique. E. coil Al was grown in a medium con- be seen (Fig. 6 ), myxovirescin A did not interfere with DNA and protein synthesis over a period of 90 minutes, but strongly inhibited incorporation of N-acetyl-glucosamine, supposedly into the cell wall, beginning after about 30 minutes.
Discussion
It appears that the myxovirescins are a family of new antibiotics, with myxovirescin A as the main representative1) (Fig. 1) . After the new antibiotics myxothiazol2,3) and myxovalargin (D.P.A. MOn-CHEN, Patent 29,24,006, Dec. 18, 1980), and two compounds that were already known from other bacteria, viz. althiomycin4) and pyrrolnitrin5), this is the fifth antibiotic isolated by us from myxobacteria.
Myxovirescin A is a particularly efficient inhibitor of enterobacteria (MIC around 1 yg/ml; Table 1 ; Fig. 2 ), but also other Gram-negative bacteria, including pseudomonads, and even some Gram-positive organisms were inhibited at acceptable concentrations (MIC around 30 pig/ml). The producing organism itself was originally very sensitive against its own antibiotic (MIC 0.5 Fng/ml). Eukaryotes seem to be completely resistant. The inhibitory spectrum would fit to the observation that myxovirescin A blocked rather specifically the incorporation of N-acetyl-glucosamine into cellular macromolecules, i. e. very probably interferes with murein synthesis (Fig. 6) . This hypothesis is supported by other observations. Thus, the antibiotic acts rather slowly, but its effect is irreversible. Or, the dose response curves for Gram-negative bacteria and for Gram-positive Staphylococcus aureus differ substantially, with the Gramnegative ones showing a much sharper reaction. The synergistic effect of EDTA in the case of Gramnegative bacteria (Fig. 4 ) may have to do with changes at the cell surface. Either permeability for the antibiotic is increased, although the rather low MIC values for enterobacteria seem to indicate that permeability is not a serious problem; or surface layers are destabilized by complex formation of EDTA with divalent cations. Murein defects caused by the antibiotic would thus sooner become deleterious. The protective effect of calcium ions (Fig. 3 ) could be interpreted on the same line.
Addition of serum to the test medium sharply decreased the activity of myxovirescin A (Fig. 5 ). Serum contains appreciable amounts of phospholipids and cholesterol (up to 0.3 % each), and it appears that the phospholipids of the serum are the interfering agents. For, addition of the albumin fraction of serum influenced the MIC but little, while small quantities of lecithin totally abolished the effect of the antibiotic.
The myxovirescins seem not to be uncommon among myxobacteria. After the antibiotics had been and kindly supplied to us by Mr. G. WIDERA, GBF). There are also similarities between the myxovirescins and the antibiotic TA from M. xanthus TA6,7), the chemical structure of which is not yet known, notably with respect to the mechanism of action8) and the producing organism. According to published data, antibiotic TA differs, however, from the myxovirescins in its inhibitory spectrum (no inhibition of Serratia marcescens, inhibition of Salmonella typhimurium and Proteus morgan i only at very high concentrations, good activity against several Bacillus strains), in its UV and IR spectrum, molecular weight and molar extinction coefficient. Contrary to the myxovirescin family, antibiotic TA is described as a single compound.
